Study suggests refrigerated canine platelets may last 14 days: full analysis

A new canine transfusion medicine study is adding momentum to an old question with fresh relevance: can platelet concentrates be stored cold for longer without losing too much clinical utility? In the Journal of Veterinary Emergency and Critical Care, investigators reported that canine platelet concentrate units stored at 4°C for 14 days maintained viability, showed no reported bacterial contamination, and retained function with agonist-dependent changes, despite evidence of metabolic storage lesion such as rising lactate. Taken together, the findings suggest refrigerated storage could help extend shelf life beyond the standard room-temperature model used for fresh platelet products. (pubmed.ncbi.nlm.nih.gov)

That matters because platelet availability remains a persistent weak point in small animal transfusion practice. Traditional canine platelet concentrates are generally stored at room temperature with agitation for only a few days, which makes them expensive to maintain, easy to outdate, and difficult for many practices to stock reliably. Earlier canine studies found that room-temperature platelet concentrates could remain viable microbiologically for up to seven days, but function declined over time, and more recent quality-control work highlighted measurable storage lesions even within five days. (pubmed.ncbi.nlm.nih.gov)

The new study’s signal is not that cold storage eliminates storage lesion. It doesn’t. Instead, it suggests the lesions may be acceptable, or at least manageable, over a longer storage interval than current practice usually allows. That distinction is important. In both veterinary and human transfusion medicine, cold-stored platelets are often viewed as a tradeoff product: they may circulate for less time after transfusion, but they can preserve aspects of immediate hemostatic performance and reduce some of the operational risks tied to room-temperature storage, particularly bacterial proliferation. Human transfusion literature has increasingly explored 14- to 21-day cold storage strategies, though experts still note unanswered questions about in vivo recovery, survival, and which bleeding patients benefit most. (mdpi.com)

There’s also a broader canine context here. Refrigerated whole blood studies in dogs have shown that clot strength can remain fairly well preserved through 21 days, even as platelet aggregation responses and some coagulation parameters drift over time. That doesn’t prove cold-stored platelet concentrate will perform the same way clinically, but it does support the idea that refrigerated canine blood products may retain meaningful hemostatic potential longer than conventional assumptions suggest. (pubmed.ncbi.nlm.nih.gov)

Industry and clinical interest in alternative platelet products is already moving in that direction. A separate multicenter retrospective study published in early 2026 evaluated lyophilized platelets in 68 dogs treated at two university hospitals between 2018 and 2022. Thirty-five dogs received the product for thrombocytopenia-associated hemorrhage and 33 for nonthrombocytopenia-associated hemorrhage. As expected, platelet counts were lower in the thrombocytopenia-associated group before and after administration, and those dogs also had lower pretransfusion PCV, though PCV differences were no longer evident at 6 to 12 or 12 to 24 hours after treatment. There was no difference between groups in use of other blood products or survival to discharge, and potential complications were reported in 6% of dogs. The authors concluded that lyophilized platelets may be considered for a variety of conditions, including both thrombocytopenia-associated and nonthrombocytopenia-associated hemorrhage. Earlier randomized work had also positioned lyophilized platelets as a practical alternative to cryopreserved products in thrombocytopenic dogs. Together, those studies underscore the same market reality: veterinary teams need platelet options that are easier to store, ship, and access when a bleeding patient arrives. (pubmed.ncbi.nlm.nih.gov)

Why it matters: For veterinarians, technicians, and blood bank teams, the biggest implication is operational. A refrigerated platelet concentrate with a 14-day shelf life could change stocking decisions for specialty hospitals, academic centers, and regional blood programs. It could mean fewer outdated units, more confidence in keeping platelet products available, and faster support for dogs with severe hemorrhage, thrombocytopenia, trauma, or perioperative bleeding risk. The lyophilized platelet data reinforce the same practical theme: when products are easier to store and deploy, they may become usable across a broader range of bleeding scenarios. But the clinical caveat remains central: in vitro viability and function are not the same as proven patient benefit, and platelet count increments alone may not capture the hemostatic value of a cold-stored product. (pubmed.ncbi.nlm.nih.gov)

Expert reaction specific to this canine paper was limited in publicly available sources, but the broader expert conversation in transfusion medicine is consistent: cold-stored platelets are promising because they may be more practical and potentially more immediately hemostatic in active bleeding, yet they still need stronger outcome-based evidence. That likely applies even more in veterinary medicine, where platelet products are less widely available and clinical studies are smaller. (ashpublications.org)

What to watch: The next step is clinical validation, especially prospective studies asking whether dogs receiving 14-day refrigerated platelet concentrate have acceptable bleeding control, transfusion responses, and safety outcomes, and whether blood banks can translate these lab findings into usable shelf-life protocols. It will also be worth watching how cold-stored platelet concentrates fit alongside other emerging canine platelet products, including lyophilized formulations that have already shown retrospective real-world use in both thrombocytopenic and nonthrombocytopenic hemorrhage cases. (pubmed.ncbi.nlm.nih.gov)